Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness

References

• Vassallo R. 2013. Management of the platelet-transfusion-refractory patient. In: Sweeney JD, Lozano M, editors. Platelet transfusion therapy, 1st edn. Bethesda: AABB Press. pp 321–358
   Google Scholar
• Slichter SJ. Platelet transfusion therapy. Hematol Oncol Clin North Am 2007;21:697–729
   PubMed Web of Science ®Google Scholar
• Sesok-Pizzini D, Herman JH. 2011. Platelet transfusion therapy. In: Mintz PD, editor. Transfusion therapy. Clinical principles and practice, 3nd edn. Bethesda: AABB Press. pp 397–432
   Google Scholar
• Brand A, Novotny V, Tomson B. Platelet transfusion therapy: From 1973 to 2005. Hum Immunol 2006;67:413–418
   Google Scholar
• Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;105:4106–4114
   PubMed Web of Science ®Google Scholar
• Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861–1869
   Google Scholar
• Zeigler ZR, Shadduck RK, Rosenfeld CS, Mangan KF, Winkelstein A, Oral A, Ramsey GE, Duquesnoy RJ. High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion. Blood 1987;70:1433–1436
   PubMed Web of Science ®Google Scholar
• Lee EJ, Norris D, Schiffer CA. Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion. Transfusion 1987;27:245–247
   PubMed Web of Science ®Google Scholar
• Schiffer CA, Hogge DE, Aisner J, Dutcher JP, Lee EJ, Papenberg D. High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients. Blood 1984;64:937–940
   Google Scholar
• Kickler T, Braine HG, Piantadosi S, Ness PM, Herman JH, Rothko K. A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenic patients. Blood 1990;75:313–316
   PubMed Web of Science ®Google Scholar
• Bensinger WI, Buckner CD, Clift RA, Slichter SJ, Thomas ED. Plasma exchange for platelet alloimmunization. Transplantation 1986;41:602–605
   Google Scholar
• Christie DJ, Howe RB, Lennon SS, Sauro SC. Treatment of refractoriness to platelet transfusion by protein A column therapy. Transfusion 1993;33:234–242
   PubMedGoogle Scholar
• Branda RF, Miller WJ, Soltis RD, McCullough JJ. Immunoadsorption of human plasma with protein A-sepharose columns. Transfusion 1986;26:471–477
   Google Scholar
• Lopez-Plaza I, Miller K, Leitman SF. Ineffectiveness of protein A adsorption in the treatment of platelet refractoriness. J Clin Apher 1992;7:33
   Google Scholar
• Yu QH, Shen YP, Ye BD, Zhou YH. Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome. Platelets 2013
   Google Scholar
• Pons-Estel GJ, Salerni GE, Serrano RM, Gomez-Puerta JA, Plasin MA, Aldasoro E, Lozano M, Cid J, Cervera R, Espinosa G. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: Report of 31 cases and review of the literature. Autoimmun Rev 2011;10:679–684
   PubMed Web of Science ®Google Scholar
• Weinstein R. 2010. Basic principles of therapeutic blood exchange. In: McLeod BC, Weinstein R, Winters JL, Szczepiorkowski ZM, editors. Apheresis: Principles and practice, 3 edn. Bethesda: AABB Press. pp 269–294
   Google Scholar
• Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011;365:318–326
   PubMed Web of Science ®Google Scholar
• Crew RJ, Ratner LE. ABO-incompatible kidney transplantation: Current practice and the decade ahead. Curr Opin Organ Transplant 2010;15:526–530
   Google Scholar
• Mittal KK, Mickey MR, Singal DP, Terasaki PI. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 1968;6:913–927
   PubMed Web of Science ®Google Scholar
• Sanz C, Ghita G, Franquet C, Martinez I, Pereira A. Red-blood-cell alloimmunization and female sex predict the presence of HLA antibodies in patients undergoing liver transplant. Vox Sang 2010;99:261–266
   Google Scholar
• Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody–specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722–1726
   PubMed Web of Science ®Google Scholar
• Sanz C, Freire C, Alcorta I, Ordinas A, Pereira A. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support. Transfusion 2001;41:762–765
   Google Scholar
• Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977;2:219–226
   Google Scholar
• Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224–232
   PubMed Web of Science ®Google Scholar
• Slichter SJ, Bolgiano D, Kao KJ, Kickler TS, McFarland J, McCullough J, Woodson R. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: Implications for using modified blood products. Transfus Med Rev 2011;25:102–110
   Google Scholar
• Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, Smithwick EM, O'Malley J, Barandun S, Hilgartner MW. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983;62:480–486
   PubMed Web of Science ®Google Scholar
• Stasi R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001;98:952–957
   PubMed Web of Science ®Google Scholar
• Auger S, Duny Y, Rossi JF, Quittet P. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: A meta-analysis. Br J Haematol 2012;158:386–398
   PubMed Web of Science ®Google Scholar
• Pavenski K, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N. Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: A systematic review. Transfusion 2013;53:2230–2242
   Google Scholar
• Shah BR, Laupacis A, Hux JE, Austin PC. Propensity score methods gave similar results to traditional regression modeling in observational studies: A systematic review. J Clin Epidemiol 2005;58:550–559
   PubMed Web of Science ®Google Scholar